Background and study aim: Portal hypertension (PH) is a frequent complication of cirrhosis, contributing to the development of ascites, esophageal varices (EV) and hepatic encephalopathy. The best available methodology for the assessment of PH is measurement of the hepatic vein pressure gradient (HVPG). However, the performance of HVPG is limited to highly specialized centers and requires extensive experience Predicting the presence, grading and follow up of esophageal varices by non-invasive means might increase compliance and would permit to restrict the performance of endoscopy to those patients with a high probability of having varices.
INTRODUCTION
Portal hypertension (PH) is a frequent complication of cirrhosis, contributing to the development of ascites, esophageal varices (EV) and hepatic encephalopathy.
The best available methodology for the assessment of PH is measurement of the hepatic vein pressure gradient (HVPG). However, the performance of HVPG is limited to highly specialized centers and requires extensive experience and therefore is not used routinely [1] .
Accordingly, the introduction of noninvasive methods able to predict the stage of PH (i.e., not clinically significant, significant, and severe) could help to identify patients who are subjected to measurement of HVPG and, ultimately, optimize the diagnostic management of cirrhotic patients.
Several studies had shown that measurement of liver stiffness (LS) by transient elastography (TE) may represent a rapid and noninvasive method for predicting the presence of clinically significant (ie, HVPG ≥10 mm Hg) or severe (ie, HVPG ≥12 mm Hg) PH [2] . On the other hand, LS shows a poor correlation with HVPG values ≥12 mm Hg, because of the increased incidence of extrahepatic factors conditioning the progression of PH [3] .
Consequently, it is not surprising that LS is not an adequate method for prediction of the presence and grade of EV (and none of the thus far proposed noninvasive methods can be considered equivalent to measurement of HVPG or endoscopy in terms of overall accuracy [4] .
Splenomegaly plays an important role in the pathophysiology of PH by increasing splanchnic inflow [5] .
However, although splenomegaly represents a common finding in patients with cirrhosis and PH, the relationship between spleen size and PH grading or EV degree is controversial [6] .
The possibility of predicting the presence of EV by using clinical parameters related to splenomegaly was initially suggested by the use of the spleen diameter, assessed by ultrasonography (US), in the platelet count/spleen diameter ratio (Plt/Spl) [7] .
Recently, a direct correlation between splenic stiffness (SS), assessed by magnetic resonance elastography, and HVPG has been reported in a large animal model of PH [8] . Accordingly, the possibility of detecting the presence of EV by the measurement of SS by TE in cirrhotic patients has also been recently proposed [9] .
This possibility is truly intriguing because splenomegaly in cirrhosis is characterized by enlargement and hyper activation of the splenic lymphoid tissue, as well as increased angiogenesis and fibrogenesis, in addition to passive congestion due to PH [10].
Regardless, a precise characterization of the relationship between SS and PH with relative complications, particularly the presence of EV, is still lacking.
This study aimed to determine efficacy of splenic stiffness measurement as a non-invasive tool in predicting the presence of esophageal varices in patients of liver cirrhosis evaluate validity of fibro scan of spleen in follow up degree of esophageal varices in patients of liver cirrhosis, Measure the ability of splenic stiffness measurement to determine grade of esophageal varices.
PATIENTS AND METHODS
This is a case control study which carried out in Gastroenterology and Hepatology Unit, Tropical Medicine Department, Faculty of Medicine, Zagazig University Hospitals, Egypt during the period from January 2015 to January 2017.This study included 117 individuals who were divided into two groups:  Group I: included 39 normal individuals as a control group for splenic stiffness measurement.  Group II: included 78 cirrhotic patients.
Diagnosis of cirrhosis based on laboratory &imaging parameters. All patients of group II was subjected to upper GIT endoscopy and according to the results this group was subdivided into patients had no varices (IIa) and patients had esophageal varices (IIb).
Informed consent was taken from all participants before participating in the study. 9-Measurement of SS: SS values were obtained using the FibroScan with the same probe used to perform LS after at least 6 hours of fasting and under US assistance. In the absence of guidelines for the measurement of SS by FibroScan, the same guidelines for the measurement of LS were applied (i.e., success rate, IQR, and IQR/M), with some adjustments due to individual spleen anatomic characteristics.
In particular, with the patient in a supine position with maximal abduction of the left arm, the probe was positioned in an intercostal space where the spleen was correctly visualized by US. Measurement of SS at presentation and after 6 months of treatment for cirrhotic group. 
Statistical analysis:
All data were collected, tabulated and statistically analyzed using SPSS 20.0 for windows. Quantitative data were expressed as the mean ± SD & median (range), and qualitative data were expressed as an absolute frequencies ''number''& relative frequencies (percentage 
RESULTS
This study showed no statistically significant difference between demographic data in cirrhotic patients and apparently healthy control as shown in (7), (8) and figure (2) with comparison of these values regarding presence of cirrhosis, presence of varices and bleeding varices with LSM, APRI and PSR. On follow up of cirhhotic patients after six months of medical and endoscopic treatment of varices. There was no statistically significant difference of initial SSM and after 6 months of inderal treatment among cirrhotic patients with small varices while there was statistically significant difference of initial SSM and after 6 months cirrhotic patients with large and gastic varices after band ligation and gastric varices injection (Table 9) . 
DISCUSSION
Development of esophageal varices (EV) is a common complication of liver cirrhosis, therefore endoscopic screening for EV in cirrhotic patients is recommended by clinical guidelines [11] . Because of the impact of upper gastric bleeding caused by EV in prognosis of cirrhotic patients, Baveno IV 2005 consensus work shop [15] , and the American Association for the study of liver disease (AASLD) had determined that every patient diagnosed with cirrhosis should be investigated for presence of EV regardless child class and the cause. The splenomegaly developing in the context of liver cirrhosis is commonly ascribed to blood congestion, but older studies demonstrated that it cannot be considered only as a consequence of increased portal pressure and augmented resistance to splenic vein outflow [16] . Surprisingly, no relationship could be found between the spleen size and the degree of esophageal varices [17] . Multiple studies demonstrated pooling of blood in the red pulp, intraparenchymal arterial aneurysms, and other multiple histopathologic changes, which evolve towards diffuse fibrosis of the spleen [18] . So, in this study, it is only logical to presume that the increase in size should determine changes in the spleen's density as well, which is a physical parameter that may be quantified by elastography.
This study showed significant increase in liver and splenic stiffness values in cirrhotic patients as compared with controls which are consistent with Bureau et al. [19] and Stefanescu et al. [20] . In this study among cirrhotic group 33 patients (42.3%) had no varices, 45 patients (57.7%) had varices.
This study revealed highly significant increase in portal vein diameter, splenic bipolar diameter, total and direct bilirubin, INR and prothrombin time in patients who had oesophageal varices (EV) between cirrhotic patients with and without varices respectively and these results was in accordance with Schepis et al. [21] who showed that high portal vein diameter serve as a predictor for presence of EV and with Sharma et al. [22] who concluded that increase splenic bipolar diameter in patients with EV. Also there is highly significant decrease in platelet count and albumin in patients who had EV compared to patients who had no varices in cirrhotic group and this is consistent with [23] .
Non invasive methods of liver fibrosis detection as liver stiffness measurement (LSM), Splenic stiffness measurement ( SSM), Platelet count/spleen diameter ratio (PSR) and AST to platelet ratio index (APRI) and its relation to portal hypertension and so oesophageal varices prediction was studied by many authors as Saad et al. [22] .
In this study there is a highly significant difference between patients with EV and those without regarding the spleen diameter, Platelet count/spleen diameter ratio (PSR) AST to platelet ratio index, (APRI), Liver stiffness measurement (LSM) and Splenic stiffness measurement( SSM). These results are consistent with Saad et al. [24] . Also, SSM and LSM were evaluated by Calvaruso et al. [25] . This study concluded a highly significant difference in mean SSM values between patients with EV and those without (64.5 versus 24.6 kPa respectively; P<0.001).
In this study SSM had a cut of ≥39.5 kpa for the presence of EV, with 97.7%,96.9% sensitivity and specificity respectively and PPV 97.8% , NPV 97%, and AUROC 0.999, while LSM had lower sensitivity and specificity 84.44%,60.61% respectively and low PPV and NPV 74.5%, 74.1%, respectively and AUROC 0.641.So SSM is more sensitive and specific than LSM in the prediction of EV, these results are in agreement with Mohsen et Also, Colecchia et al. [29] concluded that SSM and LSM were more accurate than other noninvasive parameters in identifying patients with EV. In their study, LSM could predict EV with cut-off ≥25 with sensitivity 56% and specificity 97%, while SSM could predict EV with cut-off value ≥55 with sensitivity 71% and specificity 95%. According to our study SSM showed better performance than LSM, Also SSM was the most sensitive parameter when compared with APRI, PSR and LSM as regards EV detection, PSR came in the 2 nd place similarly. So this study showed moderate performance of SS and superiority of PSR which may be explained by hemodynamic changes at time of attack may affect platelet count, also SS not measured at the same time.
In this study all patients with small oesophageal varices underwent pharmacological treatment and follow up of splenic stiffness after 6 months. There was no statistically significant difference between initial SSM measurement and SSM after 6 months with p value 0.004, This may be attributed to short period of follow up, to be evaluated by further studies. While patients with large EV and gastric varices who underwent endoscopic band ligation and endoscopic injection respectively there was statistically significant increase of SSM after 6 months with p value <0.001 which may be explained by closure of collateral channels in the form of oesophageal and gastric varices and this reflected as increased splenic congestion and fibrosis and so increased SSM.
From this study and its results we concluded that Spleen stiffness measurement by Fibroscan is a sensitive and reliable method for detection of esophageal varices.
Splenic stiffness showed the best performance on detection of oesophageal varices, when compared to other non invasive predictors, PSR came in the 2nd place.
Splenic stiffness measurement can differentiate small and large varices.
Splenic stiffness measurement can not be used as a tool for follow up of patients with oesophageal varices, who under went either pharmacological or endoscopic treatment.
